Synaptogenix Inc (SNPX)

[runncoach]

Neurodiagnostics patent application updated last week.
Interesting for those who follow the science how the tool works. Shows how to predict the state of impairment and even predictive of the pace of the disease based on total number of synapses and other metrics and measurements such as pkce levels. There are two tabs under the link. The second (documents) has PDF links to description and the drawings. Once again this isn't a Neurotrope patent but shows how Alkon is working with the FDA on PKCe as a biomarker and its relevance to bryostatin's MOA and potential likelihood of cognitive improvement.

https://patentscope.wipo.int/search/en/detail.jsf?docId=EP235558402&tab=NATIONALBIBLIO&office=&prevFilter=&sortOption=Pub+Date+Desc&queryString=FP%3A%28daniel+alkon%29&recNum=1&maxRec=319